Whole-Body MRI Accurate for Non-Small Cell Lung Cancer Staging
There was no difference in sensitivity or specificity for whole-body MRI, standard pathway for staging.
Lung Cancer
American Cancer Society Sets Goal to Cut Cancer Mortality 40% by 2035
Goal based on decrease in overall cancer death rates at pace seen in college graduates.
Estimated 15 Million Patients Will Need First-Course Chemotherapy in 2040
An estimated 15 million patients will require first-course chemotherapy in 2040.
Rates of Lung Cancer Screening Discussions Low Between Physicians and Patients
The rate of discussions between physicians and patients regarding lung cancer screenings is very low.
Use of Inhaled Corticosteroids Reduces Lung Cancer Risk in COPD
Sustained use of inhaled corticosteroids is associated with a reduced risk for lung cancer in patients with COPD.
Radiologists Outperform Vancouver Risk Model in Detecting Malignant Lung Cancer
Experienced and trainee radiologists had superior ability to predict the risk for lung cancer compared with the Vancouver model.
Improvement Needed in Doctor-Patient Lung Cancer Screening Discussions
Among individuals across the spectrum of lung cancer risk, efforts are needed to improve physician-patient discussion about lung cancer screening.
Pembrolizumab Improves Survival vs Chemotherapy in NSCLC
Treatment with pembrolizumab may be more effective than chemotherapy for improving overall survival in patients with locally advanced or metastatic non-small-cell lung cancer.
Pembrolizumab Gains Expanded Monotherapy Indication for First-Line Treatment of NSCLC
The FDA has approved Keytruda as monotherapy for the first-line treatment of patients with stage III NSCLC.
Complementary, Alternative Medicine Use High in Cancer Patients
One-third of cancer patients and survivors use complementary and alternative medicine.
Next post in Lung Cancer
